Advertisement
Advertisement
-
Business /

Companies

Related Topics:
China’s private sector

Wave of Chinese biotech deals builds with US$1.2 billion Harbour BioMed pact

Deal involving an antibody asset ‘goes beyond a traditional licensing transaction’, founder and CEO says.

China’s EV insurers move towards profitability on higher premiums, AI adoption

After boost from viral dance challenge, Chinese medicine firm’s shares languish

Slumping profits at Shandong Xinhua Pharmaceutical have dragged the shares to about HK$7 in December 2025 from HK$15.62 in December 2022.

Advertisement
Advertisement
Advertisement

Budweiser and Heineken face polar opposite fates in China as punters stay home

Beer drinkers in China are veering away from bars and high-end restaurants, instead opting for cheaper stay-at-home options, analysts say.

videocam
Heineken beers are becoming a popular choice for stay-at-home drinkers in China, according to the end of year sales results. China was one of the top three contributors to Heineken’s net profit in 2025. Photo: Reuters
Help preserve 120 years of quality journalism.
SUPPORT NOW